Skip to main content
Medical information Clinical review pending

Genetic Testing

Haemophilia A B Gene Panel

The Haemophilia A B Gene Panel is a genetic test to identify mutations in the F8 and F9 genes associated with Haemophilia A and B, hereditary bleeding disorders. This test helps understand genetic risks and informs treatment decisions.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Peripheral blood collected in an EDTA Vacutainer tube (3 ml).
Results
Results are typically available within 4-6 weeks. Confirm with the laboratory before booking.
Preparation
No specific patient preparation is required. A doctor's prescription is needed, except for cases related to surgery, pregnancy, or travel abroad.
Test priceKSh 72,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Haemophilia A B Gene Panel test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Family history of haemophilia or bleeding disorders.
  • ✓Symptoms suggestive of a bleeding disorder (e.g., excessive bleeding, easy bruising).
  • ✓Assessment of bleeding risk before surgery.
  • ✓Evaluation during pregnancy for potential bleeding risks.
  • ✓Carrier screening for females with a family history.
  • ✓Confirmation of diagnosis in suspected cases.
02

In plain language

What this test helps you understand

This test helps identify specific gene mutations causing Haemophilia A and B, aiding in diagnosis, risk assessment for family members, and guiding treatment strategies for bleeding disorders.
The Haemophilia A B Gene Panel is a specialized genetic test used to diagnose haemophilia, a condition where the blood doesn't clot properly due to a lack of specific clotting factors. This test looks for changes (mutations) in two key genes: the F8 gene, linked to Haemophilia A, and the F9 gene, linked to Haemophilia B. Identifying these mutations is crucial for understanding the cause of the bleeding disorder and guiding appropriate medical care.

This test analyzes your genetic material to determine if you carry mutations associated with Haemophilia A or B. Understanding your genetic status can provide valuable information for managing your health and planning for the future.

Taking this test can offer several benefits, including early identification of a predisposition to haemophilia, helping you and your doctor make informed decisions about treatment and management. It can also provide clarity on bleeding risks, especially if you are considering surgery or pregnancy.

Results will indicate the presence or absence of specific mutations in the F8 and F9 genes. It's important to discuss your results with a healthcare professional who can interpret them in the context of your personal and family medical history and advise on any necessary follow-up steps.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required. A doctor's prescription is needed, except for cases related to surgery, pregnancy, or travel abroad.
SamplePeripheral blood collected in an EDTA Vacutainer tube (3 ml).
MethodologyGenetic analysis techniques are used to sequence and analyze the F8 and F9 genes for specific mutations.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects mutations in the F8 and F9 genes but may not identify all possible mutations associated with haemophilia. Results should be interpreted by a qualified healthcare professional in conjunction with clinical findings and family history. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Haemophilia is a rare, inherited bleeding disorder where the blood does not clot properly due to a lack of specific clotting factors.
This test helps identify the specific genetic mutations causing Haemophilia A or B, which is crucial for accurate diagnosis, understanding risks, and planning appropriate treatment.
Individuals with a family history of haemophilia, those experiencing symptoms like excessive bleeding or bruising, or those planning surgery or pregnancy should consider this test.
A small sample of peripheral blood is collected in a specific tube (EDTA Vacutainer).
Results are generally available within 4-6 weeks, but this can vary. Confirm with the laboratory before booking.
Yes, a doctor's prescription is generally required for this test, unless for specific circumstances like pre-surgery, pregnancy, or travel.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp